History
  • No items yet
midpage
93 F.4th 339
6th Cir.
2024
Read the full case

Background

  • Plaintiffs in a multi-district litigation alleged that saxagliptin, a diabetes medication, caused their heart failure.
  • The SAVOR trial found a statistically significant increase in heart failure hospitalizations among saxagliptin users, leading to updated drug labeling and lawsuits.
  • Plaintiffs relied on a single general causation expert, Dr. Goyal, to establish that saxagliptin can cause heart failure.
  • The district court excluded Dr. Goyal’s testimony under Daubert, finding his methods unreliable, then granted summary judgment for defendants due to lack of admissible expert evidence.
  • Plaintiffs requested additional time to find a new expert after exclusion, which the district court denied for lack of good cause.
  • On appeal, plaintiffs challenged the expert exclusion, summary judgment, and the denial of time to find a new expert.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Exclusion of Dr. Goyal’s Testimony Goyal’s methodology (reliance on SAVOR and Bradford Hill) was sound and challenges are for the jury Goyal’s methods were unreliable: ignored contrary evidence, unqualified in animal studies, misapplied Bradford Hill Exclusion upheld: unreliable methodology under Rule 702
Summary Judgment for Defendants Other evidence (e.g., labeling, literature) was sufficient for jury on causation Expert testimony is required in medically complex cases; no reliable causation evidence Summary judgment affirmed: expert testimony was required
Denial of Time for New Expert Plaintiffs were diligent and deserved more time post-exclusion Plaintiffs had years to find an expert; more time would prejudice defendants, causing delays and costs Denial of extension affirmed: no good cause

Key Cases Cited

  • Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (test for admissibility of expert evidence)
  • Gen. Elec. Co. v. Joiner, 522 U.S. 136 (trial courts may exclude expert opinions not properly supported)
  • Kumho Tire Co. v. Carmichael, 526 U.S. 137 (courts' gatekeeping includes all expert testimony under Rule 702)
  • Phillips v. Cohen, 400 F.3d 388 (jury decides weight and credibility of admissible expert testimony)
Read the full case

Case Details

Case Name: In re Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Prods. Liability Litig.
Court Name: Court of Appeals for the Sixth Circuit
Date Published: Feb 13, 2024
Citations: 93 F.4th 339; 22-6078
Docket Number: 22-6078
Court Abbreviation: 6th Cir.
Log In
    In re Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Prods. Liability Litig., 93 F.4th 339